Inflammation promotes synucleinopathy propagation
0
조회
0
다운로드
1
인용
0
참고문헌
초록
The clinical progression of neurodegenerative diseases correlates with the spread of proteinopathy in the brain. The current understanding of the mechanism of proteinopathy spread is far from complete. Here, we propose that inflammation is fundamental to proteinopathy spread. A sequence variant of α-synuclein (V40G) was much less capable of fibril formation than wild-type α-synuclein (WT-syn) and, when mixed with WT-syn, interfered with its fibrillation. However, when V40G was injected intracerebrally into mice, it induced aggregate spreading even more effectively than WT-syn. Aggregate spreading was preceded by sustained microgliosis and inflammatory responses, which were more robust with V40G than with WT-syn. Oral administration of an anti-inflammatory agent suppressed aggregate spreading, inflammation, and behavioral deficits in mice. Furthermore, exposure of cells to inflammatory cytokines increased the cell-to-cell propagation of α-synuclein. These results suggest that the inflammatory microenvironment is the major driver of the spread of synucleinopathy in the brain.
Abstract
The clinical progression of neurodegenerative diseases correlates with the spread of proteinopathy in the brain. The current understanding of the mechanism of proteinopathy spread is far from complete. Here, we propose that inflammation is fundamental to proteinopathy spread. A sequence variant of α-synuclein (V40G) was much less capable of fibril formation than wild-type α-synuclein (WT-syn) and, when mixed with WT-syn, interfered with its fibrillation. However, when V40G was injected intracerebrally into mice, it induced aggregate spreading even more effectively than WT-syn. Aggregate spreading was preceded by sustained microgliosis and inflammatory responses, which were more robust with V40G than with WT-syn. Oral administration of an anti-inflammatory agent suppressed aggregate spreading, inflammation, and behavioral deficits in mice. Furthermore, exposure of cells to inflammatory cytokines increased the cell-to-cell propagation of α-synuclein. These results suggest that the inflammatory microenvironment is the major driver of the spread of synucleinopathy in the brain.
참고문헌 (48)
- Brundin, P., "Prion-like transmission of protein aggregates in neurodegenerative diseases", Nat. Rev. Mol. Cell Biol, 11, pp.301~307 (2010)
- Jucker, M., "Propagation and spread of pathogenic protein assemblies in neurodegenerative diseases", Nat. Neurosci, 21, pp.1341~1349 (2018)
- Raj, A., "A network diffusion model of disease progression in dementia", Neuron, 73, pp.1204~1215 (2012)
- Zhou, J., "Predicting regional neurodegeneration from the healthy brain functional connectome", Neuron, 73, pp.1216~1227 (2012)
- de Calignon, A., "Propagation of tau pathology in a model of early Alzheimer’s disease", Neuron, 73, pp.685~697 (2012)
- Liu, L., "Trans-synaptic spread of tau pathology in vivo", PLoS One, 7, pp.e31302~ (2012)
- Luk, K. C., "Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice", Science, 338, pp.949~953 (2012)
- Vaquer-Alicea, J., "Propagation of Protein Aggregation in Neurodegenerative Diseases", Annu. Rev. Biochem (2019)[DOI]
- Sacino, A. N., "Induction of CNS alpha-synuclein pathology by fibrillar and non-amyloidogenic recombinant alpha-synuclein", Acta Neuropathol. Commun, 1, pp.38~ (2013)
- Sacino, A. N., "Intramuscular injection of alpha-synuclein induces CNS alphasynuclein pathology and a rapid-onset motor phenotype in transgenic mice", Proc. Natl Acad. Sci. USA, 111, pp.10732~10737 (2014)
- Sacino, A. N., "Brain injection of alpha-synuclein induces multiple proteinopathies, gliosis, and a neuronal injury marker", J. Neurosci, 34, pp.12368~12378 (2014)
- 정병출, "Amplification of distinct α-synuclein fibril conformers through protein misfolding cyclic amplification", Experimental and Molecular Medicine, 49, pp.1~8 (2017), 생화학분자생물학회
- Lee, H. J., "Formation and removal of alpha-synuclein aggregates in cells exposed to mitochondrial inhibitors", J. Biol. Chem, 277, pp.5411~5417 (2002)
- Rockenstein, E., "Differential neuropathological alterations in transgenic mice expressing alpha-synuclein from the platelet-derived growth factor and Thy-1promoters", J. Neurosci. Res, 68, pp.568~578 (2002)
- Krishnan, V., "Calcium-sensitive adenylyl cyclases in depression and anxiety : behavioral and biochemical consequences of isoform targeting", Biol. Psychiat, 64, pp.336~343 (2008)
- Wolf, A., "A Comprehensive Behavioral Test Battery to Assess Learning and Memory in 129S6", Tg2576 Mice, 2016, pp.11, e0147733~
- Hsiao, K. K., "Age-related CNS disorder and early death in transgenic FVB", N mice overexpressing Alzheimer amyloid precursor proteins, 1995, pp.15, 1203~1218
- Kim, T. K., "G9a-Mediated Regulation of OXT and AVP Expression in the Basolateral Amygdala Mediates Stress-Induced Lasting Behavioral Depression and Its Reversal by Exercise", Mol. Neurobiol, 53, pp.2843~2856 (2016)
- Ulusoy, A., "Caudo-rostral brain spreading of alpha-synuclein through vagal connections", EMBO Mol. Med, 5, pp.1119~1127 (2013)
- Gundersen, H. J., "The efficiency of systematic sampling in stereology and its prediction", J. Microsc, 147, pp.229~263 (1987)
- Love, M. I., "Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2", Genome Biol, 15, pp.550~ (2014)
- Bindea, G., "ClueGO : a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks", Bioinformatics, 25, pp.1091~1093 (2009)
- Huang da, W., "Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources", Nat. Protoc, 4, pp.44~57 (2009)
- Lee, H. J., "Clearance and deposition of extracellular alpha-synuclein aggregates in microglia", Biochem. Biophys. Res. Commun, 372, pp.423~428 (2008)
- Bae, E. J., "LRRK2 kinase regulates alpha-synuclein propagation via RAB35phosphorylation", Nat. Commun, 9, pp.3465~ (2018)
- Bae, E. J., "Glucocerebrosidase depletion enhances cell-to-cell transmission of alpha-synuclein", Nat. Commun, 5, pp.4755~ (2014)
- De Giorgi, F., "Novel self-replicating alpha-synuclein polymorphs that escape ThT monitoring can spontaneously emerge and acutely spread in neurons", Sci. Adv, 6, pp.eabc4364~ (2020)
- Yanagisawa, D., "Curcuminoid binds to amyloid-beta1-42 oligomer and fibril", J. Alzheimers Dis, 24(Suppl 2), pp.33~42 (2011)
- Gao, H. M., "Neuroinflammation and oxidation", nitration of alpha-synuclein linked to dopaminergic neurodegeneration, 2008, pp.28, 7687~7698
- Kim, C., "Neuron-released oligomeric alpha-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia", Nat. Commun, 4, pp.1562~ (2013)
- Olanow, C. W., "Temporal evolution of microglia and alpha-synuclein accumulation following foetal grafting in Parkinson’s disease", Brain, 142, pp.1690~1700 (2019)
- Ising, C., "NLRP3 inflammasome activation drives tau pathology", Nature, 575, pp.669~673 (2019)
- Gao, H. M., "Neuroinflammation and alpha-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson’s disease", Environ. Health Persp, 119, pp.807~814 (2011)
- Gordon, R., "Inflammasome inhibition prevents alpha-synuclein pathology and dopaminergic neurodegeneration in mice", Sci. Transl. Med, 10, pp.eaah4066~ (2018)
- Lindestam Arlehamn, C. S., "alpha-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson’s disease", Nat. Commun, 11, pp.1875~ (2020)
- Choi, I., "Microglia clear neuron-released α-synuclein via selective autophagy and prevent neurodegeneration", Nat. Commun, 11, pp.1386~ (2020)
- Earls, R. H., "NK cells clear α-synuclein and the depletion of NK cells exacerbates synuclein pathology in a mouse model of α-synucleinopathy", Proc. Natl Acad. Sci. USA, 117, pp.1762~1771 (2020)
- George, S., "T Cells Limit Accumulation of Aggregate Pathology Following Intrastriatal Injection of α-Synuclein Fibrils", J. Parkinsons. Dis, 11, pp.585~603 (2021)
- Grubman, A., "A single-cell atlas of entorhinal cortex from individuals with Alzheimer’s disease reveals cell-type-specific gene expression regulation", Nat. Neurosci, 22, pp.2087~2097 (2019)
- Habib, N., "Disease-associated astrocytes in Alzheimer’s disease and aging", Nat. Neurosci, 23, pp.701~706 (2020)
- Keren-Shaul, H., "A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease", Cell, 169, pp.1276~1290.e1217 (2017)
- Srinivasan, K., "Alzheimer’s Patient Microglia Exhibit Enhanced Aging and Unique Transcriptional Activation", Cell Rep, 31, pp.107843~ (2020)
- Bae Eun-Jin, "TNF-α promotes α-synuclein propagation through stimulation of senescence-associated lysosomal exocytosis", Experimental and Molecular Medicine, 54, pp.1~13 (2022), 생화학분자생물학회[DOI]
- Ueda, J., "Perampanel Inhibits alpha-Synuclein Transmission in Parkinson’s Disease Models", Mov. Disord, 36, pp.1554~1564 (2021)
- Wu, Q., "Neuronal activity modulates alpha-synuclein aggregation and spreading in organotypic brain slice cultures and in vivo", Acta Neuropathol, 140, pp.831~849 (2020)
- Paillusson, S., "Activitydependent secretion of alpha-synuclein by enteric neurons", J. Neurochem, 125, pp.512~517 (2013)
- Yamada, K., "Extracellular alpha-synuclein levels are regulated by neuronal activity", Mol. Neurodegener, 13, pp.9~ (2018)
- Jarrett, J. T., "Seeding “one-dimensional crystallization” of amyloid: a pathogenic mechanism in Alzheimer’s disease and scrapie?", Cell, 73, pp.1055~1058 (1993)
